PPT-Implementing CRAG Screening

among HIV Patients Initiating ART in Rural HIV Clinics with Regular Absence of CD4 Testing Services in Tanzania Gladys Mbwanji Diana Faini Amina Nyuri Andrew Katende Aneth V Kalinjuma. CongHrtCoverTabs9x11 101111 1255 PM Page 1 brPage 2br Acknowledgements This material was made possible by a grant from the Elsie and Marvin Dekelboum Family Foundation The Childrens National Heart Institute and Child Health Advocacy Institute would A new . s. trategy to . p. revent . c. ryptococcal . d. eaths. Preventing cryptococcal deaths. Assembling a customised screen-and-treat . toolbox. Working towards implementation of screening in your setting. Radha Rajasingham, David Meya, Melissa Rolfes, Kate . Birkenkamp. , David R Boulware. Presented by: Radha Rajasingham, MD. July 23, 2012. Background. Cryptococcal Meningitis causes ~20-25% of AIDS-related attributable mortality in sub-Saharan Africa. Deprivation – what are your options ? . . . Tish Hanifan. Barrister . Joint Chairman. Society of Later Life Advisers. NAFAO Annual Conference . d. isease. Nelesh Govender . (on behalf of the . WHO Guidelines . Development Group). National Institute for Communicable Diseases, South Africa. Why . crypto disease was a priority OI . for . guidelines development. Deprivation . – . How to Deal with it . ? . . . Tish Hanifan. Barrister . Joint Chairman. Society of Later Life Advisers. NAFAO Annual Conference . Care . and . Treatment . Technical . C. onsiderations & . Priorities. . Dr Raymond Chimatira. Dr . Olarotimi S. . Oladoyinbo. 1. Outline. Care and . Treatment priority . a. pproaches. Treatment expansion strategy and activities. water spray Rodmilling Scalping Screening(3-05-025-11) Raw Material TransportRaw Material Storage Product Storage Wet ClassifyingProduct Storage Optional processPM emissions 11.19.1-2EMISSION FACTORS1 “Who are the addicts?”. Screening: Why screen universally?. Drinking and drug use…. are common. often go undetected. can increase risks to safety and health problems . Routine screening for other potential medical problems (e.g. cancer, diabetes, hypertension). Why not for alcohol and drug use?. Sayoki. . Mfinanga. PI-National Institute Medical Research Tanzania. Dr Cecilia . Kanyama. PI-UNC Project Malawi. Dr Charles . Kouanfack. PI-. Hôpital. Central Yaoundé, Cameroon. Dr . Sile Molloy PI/Epidemiologist. Challenges, lessons, and opportunities. Tom Ellman MSF SA IAS 2019. Conflicts of Interest. No conflicts of interest to declare. ‘Stable’ / ‘Unstable’ Continuum. Virally undetectable. Poorly adherent. cryptococcal antigen screening program: a cost-effectiveness analysis. Radha Rajasingham. , David Meya, Greg Greene, Alex Jordan, Mina Nakawuka, Tom Chiller, David Boulware, Bruce Larson. July 25, 2018. Radha Rajasingham. December 10, 2017. Background. Asymptomatic CRAG+ treated with fluconazole . 25 to 30% failure rate with meningitis and/or death seen in Uganda (ORCAS trial) and REMSTART trial in Tanzania & Zambia. National Reflex . CrAg. Screening by Province (Q4 2016-Q3 2017) . Gauteng Province. Quartelry Reflex Screening. Quartely Reflex CrAg+. Q4-2016. 16180. 1154. Q1-2017. 19616. 1071. Q2-2017. 17511. 971.